Investigational New Drugs (ERA Journal)

Investigational New Drugs is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Investigational New Drugs issns are issn1: 0167-6997 issn2: 1573-0646.

The field covered by Investigational New Drugs as part of the evaluation of Australian university research excellence is:

Pharmacology and Pharmaceutical Sciences Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Pharmacology and Pharmaceutical Sciences field include:

- American Journal of Health-System Pharmacy
- Bioanalysis
- Cancer Immunology Research
- Clinical Pharmacology: Advances and Applications
- Current Medicinal Chemistry
- Expert Opinion on Investigational Drugs
- Integrated Pharmacy Research and Practice
- International Journal of Pharmaceutical Compounding
- Journal of Advanced Pharmaceutical Technology and Research
- Journal of Continuing Education in the Health Professions
- Journal of Faculty of Pharmacy of Ankara University
- Molecular Cancer Therapeutics
- Pharmaceutical Technology Europe
- Pharmaceuticals
- Vojnosanitetski Pregled: casopis lekara i farmaceuta Srbije i Crne Gore

ERA Research Rankings Submenu

- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List

Latest News and Updates:

- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page